113 related articles for article (PubMed ID: 11367510)
1. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity.
Martin-Kleiner I; Bidlack JM
Int Immunopharmacol; 2001 Jan; 1(1):13-20. PubMed ID: 11367510
[TBL] [Abstract][Full Text] [Related]
2. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
Lawrence DM; Joseph DB; Bidlack JM
Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
[TBL] [Abstract][Full Text] [Related]
3. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
4. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
5. The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line.
Martin-Kleiner I; Bidlack JM
Int J Immunopharmacol; 1999 Feb; 21(2):133-40. PubMed ID: 10230876
[TBL] [Abstract][Full Text] [Related]
6. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
[TBL] [Abstract][Full Text] [Related]
7. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
8. Kappa opioid receptors on three related thymoma cell lines. Differences in receptor-effector coupling.
Bidlack JM; Joseph DB; Lawrence DM
Adv Exp Med Biol; 1995; 373():23-7. PubMed ID: 7668156
[No Abstract] [Full Text] [Related]
9. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
10. The kappa-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line.
Martin-Kleiner I; Gabrilovac J
Int Immunopharmacol; 2002 Jun; 2(7):975-80. PubMed ID: 12188038
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
12. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY
J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the cloned kappa and mu opioid receptors.
Tallent M; Dichter MA; Reisine T
Neuroscience; 1998 Aug; 85(3):873-85. PubMed ID: 9639280
[TBL] [Abstract][Full Text] [Related]
15. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.
Konkoy CS; Childers SR
Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004
[TBL] [Abstract][Full Text] [Related]
16. Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression.
Hirst RA; Hirota K; Grandy DK; Lambert DG
Neurosci Lett; 1997 Aug; 232(2):119-22. PubMed ID: 9302101
[TBL] [Abstract][Full Text] [Related]
17. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
Attali B; Saya D; Vogel Z
J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
[TBL] [Abstract][Full Text] [Related]
18. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
20. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor.
Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF
Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
